9.65

10.16% 0.89

After Hours: 9.65

Aligos Therapeutics Inc (ALGS)

Overview News Price History Option Chain Financials Why ALGS Down? Discussions Forecast

Aligos Therapeutics Inc stock is traded at $9.65, with a volume of 64,286. It is up +10.16% in the last 24 hours and down -3.40% over the past month. Aligos Therapeutics Inc is a clinical stage biopharmaceutical company. It is engaged in developing novel therapeutics to address unmet medical needs in viral and liver diseases, including chronic hepatitis B and coronaviruses, and therapeutics for nonalcoholic steatohepatitis (NASH). The company's pipeline includes ALG-010133, ALG-000184, ALG-020572 and ALG-055009, among others.

Previous Close:

$8.76

Open:

$8.91

24h Volume:

64,286

Relative Volume:

0.77

Market Cap:

$59.38M

Revenue:

$7.97M

Net Income/Loss:

$-75.74M

P/E Ratio:

-0.3974

EPS:

-24.2853

Net Cash Flow:

$-85.33M

1W Performance:

+3.54%

1M Performance:

-3.40%

6M Performance:

+28.67%

1Y Performance:

-76.42%

1-Day Range:

$8.91

$9.65

1-Week Range:

$8.25

$9.9999

52-Week Range:

$3.76

$40.81

Aligos Therapeutics Inc Stock (ALGS) Company Profile

Name

Aligos Therapeutics Inc

Sector

Healthcare (1116)

Industry

Biotechnology (620)

Phone

(800) 466-6059

Address

ONE CORPORATE DR., 2ND FLOOR, SOUTH SAN FRANCISCO

Employee

Twitter

Next Earnings Date

2024-11-06

Latest SEC Filings

ALGS's Discussions on Twitter

Compare ALGS with other stocks

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
ALGS Aligos Therapeutics Inc	9.65	53.91M	7.97M	-75.74M	-85.33M	-24.29
VRTX Vertex Pharmaceuticals Inc	484.15	118.84B	11.74B	3.68B	3.34B	14.19
REGN Regeneron Pharmaceuticals Inc	812.27	81.61B	14.25B	4.58B	3.88B	41.77
ALNY Alnylam Pharmaceuticals Inc	422.50	53.69B	3.21B	43.57M	221.36M	0.2405
ARGX Argen X Se Adr	822.94	49.49B	3.06B	1.28B	447.35M	19.67
INSM Insmed Inc	176.00	37.34B	447.02M	-1.18B	-906.14M	-6.1812

Aligos Therapeutics Inc Stock (ALGS) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Aug-18-25	Resumed	H.C. Wainwright	Buy
Aug-19-24	Initiated	H.C. Wainwright	Buy
Jan-06-23	Upgrade	Jefferies	Hold → Buy
Jan-06-23	Upgrade	Piper Sandler	Neutral → Overweight
Mar-23-22	Downgrade	Piper Sandler	Overweight → Neutral
Jan-07-22	Downgrade	JP Morgan	Overweight → Neutral
Jan-06-22	Downgrade	Jefferies	Buy → Hold
Sep-09-21	Initiated	SVB Leerink	Outperform
May-17-21	Resumed	Piper Sandler	Overweight
Nov-10-20	Initiated	Cantor Fitzgerald	Overweight
Nov-10-20	Initiated	JP Morgan	Overweight
Nov-10-20	Initiated	Jefferies	Buy
Nov-10-20	Initiated	Piper Sandler	Overweight

View All

Aligos Therapeutics Inc Stock (ALGS) Latest News

03:46 AM

UBS Initiates Coverage on ALGS with a Buy Rating and $20 PT | AL - GuruFocus

03:46 AM

09:35 AM

Here's Why Aligos Therapeutics (NASDAQ:ALGS) Must Use Its Cash Wisely - Yahoo Finance

09:35 AM

01:40 AM

Aligos Therapeutics stock initiated with Buy rating at UBS on liver disease pipeline - Investing.com

01:40 AM

Jan 06, 2026

(ALGS) as a Liquidity Pulse for Institutional Tactics - Stock Traders Daily

Jan 06, 2026

Jan 04, 2026

Is Aligos Therapeutics Inc a good long term investmentValue Traps to Avoid & Diversify Intelligently to Avoid Big Hits - earlytimes.in

Jan 04, 2026

Head to Head Review: Xilio Therapeutics (NASDAQ:XLO) and Aligos Therapeutics (NASDAQ:ALGS) - Defense World

Jan 04, 2026

Dec 31, 2025

Aug PreEarnings: How Aligos Therapeutics Inc 5WK0 stock reacts to fiscal policies2025 Pullback Review & Low Drawdown Momentum Trade Ideas - moha.gov.vn

Dec 31, 2025

Dec 30, 2025

Aligos Therapeutics (NASDAQ:ALGS) Stock Price Down 4.5% – Time to Sell? - Defense World

Dec 30, 2025

Aligos Therapeutics (NASDAQ:ALGS) Stock Price Down 4.5%Time to Sell? - MarketBeat

Dec 30, 2025

Dec 26, 2025

Aligos Therapeutics secures $105 million in private placement - MSN

Dec 26, 2025

Dec 25, 2025

Technical Reactions to ALGS Trends in Macro Strategies - Stock Traders Daily

Dec 25, 2025

Dec 21, 2025

Why Aligos Therapeutics Inc. stock could be next big winnerMarket Weekly Review & Weekly High Momentum Picks - Улправда

Dec 21, 2025

Dec 19, 2025

Analyst Calls: Why Aligos Therapeutics Inc. stock is rated strong buyJuly 2025 Decliners & Community Consensus Trade Signals - DonanımHaber

Dec 19, 2025

Why Aligos Therapeutics Inc. stock is a must watch in 20252025 Trade Ideas & Free Fast Gain Swing Trade Alerts - DonanımHaber

Dec 19, 2025

Aligos Therapeutics Earnings Notes - Trefis

Dec 19, 2025

How resilient is Aligos Therapeutics Inc. stock in market downturnsWeekly Investment Report & Capital Efficiency Focused Ideas - DonanımHaber

Dec 19, 2025

Dec 18, 2025

Why analysts upgrade Aligos Therapeutics Inc. stockTrade Volume Report & Free Growth Oriented Trading Recommendations - Улправда

Dec 18, 2025

Gainers Report: Does Aligos Therapeutics Inc stock trade at a discount to peers2025 Technical Overview & Expert Approved Momentum Ideas - moha.gov.vn

Dec 18, 2025

Hepatitis B Virus Infection Clinical Trial Pipeline Accelerates as 80+ Pharma Companies Rigorously Develop Drugs for Market Entry | DelveInsight - The Globe and Mail

Dec 18, 2025

Dec 14, 2025

(ALGS) and the Role of Price-Sensitive Allocations - Stock Traders Daily

Dec 14, 2025

Dec 13, 2025

What analysts say about Aligos Therapeutics Inc stockPrice-to-Earnings Ratio Insights & Minimal Investment Portfolio - earlytimes.in

Dec 13, 2025

Dec 12, 2025